FDA issues quarterly list of drugs with potential safety concerns

08/29/2010 | Reuters

Roche Holding's breast cancer drug Herceptin and Sanofi-Aventis' heart drug Multaq are on the FDA's quarterly list of treatments being investigated for possible safety risks. The list also includes Pfizer's antibiotic Cleocin, Merck & Co.'s contraceptive Implanon and Novartis' cancer treatment Afinitor.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT